Cargando…

Clinical challenges: Myeloma and concomitant type 2 diabetes

Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematological cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Mohamed Ahmed, Ahmed, Yasar A, Ibrahim, Abubaker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889067/ https://www.ncbi.nlm.nih.gov/pubmed/24455664 http://dx.doi.org/10.4103/2278-330X.119916

Ejemplares similares

Clinical Challenges: Myeloma and Concomitant Type 2 Diabetes
por: Ahmed, Yasar Albushra Abdul Rahiem, et al.
Publicado: (2013)

Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?
por: Buse, John B., et al.
Publicado: (2018)

Use of Continuous Glucose Monitoring in People with Type 1 Diabetes: Perspectives of Two People with Diabetes and Physician Perspective
por: Ahmed Mohamed, Isra, et al.
Publicado: (2019)

Beyond No Blame: Practical Challenges of Conducting Maternal and Perinatal Death Reviews in Eastern Ethiopia
por: Tura, Abera Kenay, et al.
Publicado: (2020)

COVID-19 and type 1 diabetes: Challenges and actions
por: Klatman, Emma L., et al.
Publicado: (2020)

Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
por: Ling, Charlotte
Publicado: (2022)

Influence of gut microbiome on multiple myeloma: friend or foe?
por: Ahmed, Nausheen, et al.
Publicado: (2020)

Reimagining diversity in multiple myeloma clinical trials
por: Habr, Dany, et al.
Publicado: (2022)

Concomitant lymphoplasmacytic lymphoma, multiple myeloma, and amyloidosis: A diagnostic and therapeutic challenge
por: Ceballos, Candela, et al.
Publicado: (2022)

The Diagnostic and Treatment Challenges of Concomitant Mantle Cell Lymphoma and IgM Myeloma
por: Gor, Dhairya, et al.
Publicado: (2022)

Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?
por: Strain, William David, et al.
Publicado: (2014)

Is aggressive treatment of smoldering myeloma the path to curing myeloma?
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?
por: Dixit, Vishwa Deep
Publicado: (2013)

Clinical characteristics and survival of patients with IgD multiple myeloma
por: Li, Yi, et al.
Publicado: (2021)

Living with Type 2 Diabetes: Patient Commentary in Response to the Paper ‘SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice’
por: Evans, Marc
Publicado: (2018)

Sub-Sahara Africa—The impact and challenge of type 2 diabetes mellitus requiring urgent and sustainable public health measures
por: Sinclair, AJ
Publicado: (2019)

Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges
por: Quadeer, Ahmed Abdul
Publicado: (2020)

Concomitant medications and circulating tumor cells: friends or foes?
por: Di Cosimo, Serena, et al.
Publicado: (2023)

Progress in multiple myeloma
por: Munker, Reinhold, et al.
Publicado: (2019)

Self-medication during Covid-19 pandemic: challenges and opportunities
por: Malik, Muna, et al.
Publicado: (2020)

COVID-19, Diabetes and Ramadan
por: Chowdhury, Tahseen A., et al.
Publicado: (2020)

Challenges in Understanding Diabetic Embryopathy
por: Loeken, Mary R.
Publicado: (2008)

Diabetes in China: The challenge now
por: Weng, Jianping, et al.
Publicado: (2010)

Ethical challenges in gestational diabetes
por: Asadi, Mojgan, et al.
Publicado: (2023)

Clinical Characteristics of Concomitant Diabetic Ketoacidosis in Type 2 Diabetes Patients with Acute Pancreatitis
por: Fu, Yan, et al.
Publicado: (2022)

Insulin Resistance and Type 2 Diabetes
por: Taylor, Roy
Publicado: (2012)

Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region
por: Alsaadi, Taoufik, et al.
Publicado: (2023)

Optimizing Care in Diabetes: a Quixotic Challenge
por: Friedman, Eli A.
Publicado: (2012)

Panobinostat and Multiple Myeloma in 2018
por: Yee, Andrew J., et al.
Publicado: (2018)

The Challenging Search for Diabetic Nephropathy Genes
por: Bowden, Donald W., et al.
Publicado: (2012)

Renal cell carcinoma concomitant with multiple myeloma
por: Narwal, Anubhav, et al.
Publicado: (2022)

A Case of Concomitant Multiple Myeloma and Cirrhosis
por: Hindosh, Ziad, et al.
Publicado: (2023)

A proteomic approach to obesity and type 2 diabetes
por: López-Villar, Elena, et al.
Publicado: (2015)

Circulating cytokines and outcome prediction of burned children with concomitant inhalation injury
por: Myrianthefs, Pavlos M, et al.
Publicado: (2008)

Exercise in type 2 diabetes: to resist or to endure?
por: Roden, M.
Publicado: (2012)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Commentary: Educational intervention in type 2 diabetes
por: Singh, Raminder
Publicado: (2023)

Understanding the Diabetic Brain: New Technologies but Old Challenges
por: Northam, Elisabeth A., et al.
Publicado: (2013)

Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials
por: Tanaka, Atsushi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f9mvki3adoo4mthfu5n865l5uf